Evidence map›Paper›PMID 32583937›Full record

ArticleNeuromodulation : journal of the International Neuromodulation Society2021

Improved Psychosocial and Functional Outcomes and Reduced Opioid Usage Following Burst Spinal Cord Stimulation.

Steven M Falowski, Gregory A Moore, Eric G Cornidez, J Kelby Hutcheson, Kenneth Candido, Isaac Peña, Bram Blomme, Robyn A Capobianco

Abstract read
In one paragraph

Article in Neuromodulation : journal of the International Neuromodulation Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Multicentre, clinical trial of burst spinal cord stimulation for neck and upper limb pain NU-BURST: a trial protocol.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Steven M FalowskiNeurosurgical Associates of Lancaster, Lancaster, PA, USA.ORCID https://orcid.org/0000-0003-3996-087X
Gregory A MoorePacific Sports and Interventional Spine, Eugene, OR, USA.
Eric G CornidezPain Institute of Southern Arizona, Tucson, AZ, USA.
J Kelby HutchesonCarolinas Center for Advanced Management of Pain, Columbia, SC, USA.
Kenneth CandidoChicago Anesthesia Associates Sc, Chicago, IL, USA.
Isaac PeñaHospital Universitario Virgen del Rocío, Seville, Spain.
Bram BlommeAbbott (formerly St Jude Medical), Austin, TX, USA.
Robyn A CapobiancoAbbott (formerly St Jude Medical), Austin, TX, USA.

Funding

Abbott Laboratories
6 · The paper itself

Abstract

objectiveBurst spinal cord stimulation (B-SCS) has been shown to reduce neuronal firing in the anterior cingulate cortex through selective modulation of the medial pain pathway tract. This pain pathway communicates the affective component of pain processing. The purpose of this study was to assess the effect of B-SCS on psychosocial functioning and its influence on pain and quality of life. MATERIALS AND

methodsEligible patients with chronic, intractable pain of the trunk, and/or lower limbs were enrolled. After a successful trial period, subjects received a permanent implant and returned for follow-up at 6- and 12-months.

resultsIn total, 269 patients were enrolled at 22 centers. Trial success rate was 90%. Significant improvements in pain, physical, mental, and emotional functioning were observed from baseline to the 6- and 12-month follow-up (p < 0.001). Overall, patients had improved quality of life, became more active, and the negative impact of pain on daily life was decreasing. At one year, 81% of subjects were satisfied or very satisfied with their therapy. Subjects showing significant improvements on mental health outcomes reported enhanced pain relief and quality of life scores compared with subjects with continued impaired mental health at follow-up. At one year, 89% of subjects who were taking opioids at baseline decreased or stayed at the same level of opioid use; 19% stopped taking any opioids. No unanticipated adverse events have been reported.

conclusionsOne-year outcomes after B-SCS show improvements across all evaluated psychological measures with the largest impact observed on catastrophizing and depression (the affective component of pain processing). These pain-related beliefs and behaviors, and not pain intensity, have been shown to put patients at greatest risk of a poor prognosis and quality of life.

Indexed as

Chronic PainSpinal Cord StimulationAnalgesics, OpioidHumansPain ManagementQuality of LifeSpinal CordTreatment OutcomeAnalgesics, OpioidBurstchronic painmedial pain pathway tractopioid therapypatient reported outcomes

Identifiers

PMID32583937
PMCPMC8247278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.